OBSOLETE: Acquired metabolic neuropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:206616
Who is this for?
Show terms as
10Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acquired metabolic neuropathy is a condition where nerve damage occurs as a result of metabolic problems that develop during a person's lifetime, rather than being inherited from birth. This means the nerves — especially those in the hands and feet — become damaged because of an underlying metabolic disorder such as diabetes, kidney failure, liver disease, thyroid problems, or nutritional deficiencies (like lack of vitamin B12). The term 'acquired' means this is not something you are born with but something that develops over time due to another health condition. It is important to note that this specific Orphanet entry (206616) is marked as OBSOLETE, meaning it is no longer actively used as a standalone classification. Patients with nerve damage from metabolic causes are now typically classified under more specific diagnoses based on the underlying cause (for example, diabetic neuropathy or uremic neuropathy from kidney disease). Symptoms commonly include numbness, tingling, burning pain, and weakness in the hands and feet, which can gradually spread. Some people also experience problems with balance, digestion, or blood pressure regulation. Treatment focuses on managing the underlying metabolic condition and relieving nerve pain. When the root cause is identified and treated early, nerve damage can sometimes be slowed or partially reversed. Pain management, physical therapy, and lifestyle changes are important parts of care.

Key symptoms:

Numbness or tingling in hands and feetBurning or shooting pain in the extremitiesMuscle weakness in the legs or armsLoss of balance or coordinationSensitivity to touchDifficulty walkingMuscle crampsLoss of reflexesDigestive problems such as nausea or constipationDizziness when standing upDifficulty gripping objectsFeeling of wearing invisible gloves or socksFoot ulcers or wounds that heal slowly

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Median and Ulnar Nerve Function in Tattoo Artists

Gazi University

TrialRECRUITING
Mar 2026The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

Universitas Sebelas Maret — PHASE2, PHASE3

TrialNOT YET RECRUITING
Feb 2026Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy

National Taiwan University Hospital — NA

TrialENROLLING BY INVITATION
Jan 2026SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

University of Rochester — PHASE2

TrialNOT YET RECRUITING
Jan 2026Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

Taipei Veterans General Hospital, Taiwan — NA

TrialNOT YET RECRUITING
Oct 2025Multimodal Ultrasound in Peripheral Neuropathy

Assiut University

TrialNOT YET RECRUITING
Aug 2025Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

Ka-Wai Ho — NA

TrialNOT YET RECRUITING
Jul 2025Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

Ain Shams University — PHASE2

TrialRECRUITING
Feb 2025Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire

Cairo University

TrialRECRUITING
Feb 2025The Effect of Piracetam on Diabetic Peripheral Neuropathy Patients

Ain Shams University — PHASE4

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Acquired metabolic neuropathy.

10 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

10 recruitingView all trials with filters →
Phase 21 trial
Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
Phase 2
Actively Recruiting
· Sites: Cairo · Age: 4075 yrs
Phase 11 trial
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia
Phase 1
Actively Recruiting
PI: Chadwick Prodromos, MD (The Foundation for Orthopaedics and Regenerative M) · Sites: St John's
N/A5 trials
The Effect of Cold Therapy on Peripheral Neuropathy
N/A
Actively Recruiting
· Sites: Istanbul · Age: 718 yrs
High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
N/A
Actively Recruiting
PI: BiFa Fan, master (China-Japan Friendship Hospital) · Sites: Beijing · Age: 1880 yrs
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
N/A
Actively Recruiting
PI: Robert McCarthy, PharmD (Rush University Medical Center) · Sites: Chicago, Illinois · Age: 1890 yrs
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
N/A
Actively Recruiting
PI: Brian Dalm, MD (Ohio State University) · Sites: Columbus, Ohio · Age: 1899 yrs
Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy
N/A
Enrolling by Invitation
· Sites: Taipei · Age: 2080 yrs
Other3 trials
Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire
Actively Recruiting
PI: Engy BadrEldin S Moustafa, PhD (Faculty of Physical Therapy, Cairo University, Egy) · Sites: Cairo, Giza Governorate · Age: 1870 yrs
Median and Ulnar Nerve Function in Tattoo Artists
Actively Recruiting
· Sites: Ankara · Age: 1899 yrs
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
Actively Recruiting
PI: John T Slevin, M.D., M.B.A. (University of Kentucky Department of Neurology) · Sites: Lexington, Kentucky; Lexington, Kentucky · Age: 1899 yrs

No specialists are currently listed for OBSOLETE: Acquired metabolic neuropathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Acquired metabolic neuropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Acquired metabolic neuropathyForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Acquired metabolic neuropathy.

Start the conversation →

Latest news about OBSOLETE: Acquired metabolic neuropathy

No recent news articles for OBSOLETE: Acquired metabolic neuropathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the specific metabolic cause of my neuropathy, and how can we treat it?,Can the nerve damage I already have be reversed, or is the goal to prevent it from getting worse?,What medications are best for managing my nerve pain, and what are their side effects?,Should I see any additional specialists, such as a pain management doctor or physical therapist?,What can I do at home to protect my feet and prevent injuries?,Are there any dietary changes or supplements that could help my condition?,How often should I have follow-up nerve testing to monitor my progress?

Common questions about OBSOLETE: Acquired metabolic neuropathy

What is OBSOLETE: Acquired metabolic neuropathy?

Acquired metabolic neuropathy is a condition where nerve damage occurs as a result of metabolic problems that develop during a person's lifetime, rather than being inherited from birth. This means the nerves — especially those in the hands and feet — become damaged because of an underlying metabolic disorder such as diabetes, kidney failure, liver disease, thyroid problems, or nutritional deficiencies (like lack of vitamin B12). The term 'acquired' means this is not something you are born with but something that develops over time due to another health condition. It is important to note that

How is OBSOLETE: Acquired metabolic neuropathy inherited?

OBSOLETE: Acquired metabolic neuropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Acquired metabolic neuropathy typically begin?

Typical onset of OBSOLETE: Acquired metabolic neuropathy is adult. Age of onset can vary across affected individuals.

Are there clinical trials for OBSOLETE: Acquired metabolic neuropathy?

Yes — 10 recruiting clinical trials are currently listed for OBSOLETE: Acquired metabolic neuropathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.